BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 15526008)

  • 1. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
    Raina R; Pahlajani G; Agarwal A; Zippe CD
    BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Lakin MM; Thukral M; Agarwal A; Ausmundson S; Montague DK; Klein E; Zippe CD
    Int J Impot Res; 2003 Oct; 15(5):318-22. PubMed ID: 14562131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Mascha E; Montague DK; Klein E; Zippe CD
    Urology; 2004 May; 63(5):960-6. PubMed ID: 15134989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy.
    Raina R; Nandipati KC; Agarwal A; Mansour D; Kaelber DC; Zippe CD
    J Androl; 2005; 26(6):757-60. PubMed ID: 16291971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function.
    Raina R; Agarwal A; Ausmundson S; Lakin M; Nandipati KC; Montague DK; Mansour D; Zippe CD
    Int J Impot Res; 2006; 18(1):77-81. PubMed ID: 16107868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.
    Nandipati K; Raina R; Agarwal A; Zippe CD
    Int J Impot Res; 2006; 18(5):446-51. PubMed ID: 16482200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
    Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
    J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil citrate after radical retropubic prostatectomy.
    Lowentritt BH; Scardino PT; Miles BJ; Orejuela FJ; Schatte EC; Slawin KM; Elliott SP; Kim ED
    J Urol; 1999 Nov; 162(5):1614-7. PubMed ID: 10524880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A; Gallina A; Zanni G; Briganti A; Dehò F; Saccà A; Suardi N; Barbieri L; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function after male radical cystectomy in a sexually active population.
    Zippe CD; Raina R; Massanyi EZ; Agarwal A; Jones JS; Ulchaker J; Klein EA
    Urology; 2004 Oct; 64(4):682-5; discussion 685-6. PubMed ID: 15491700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy.
    Mydlo JH; Viterbo R; Crispen P
    BJU Int; 2005 Apr; 95(6):843-6. PubMed ID: 15794795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy.
    Raina R; Agarwal A; Allamaneni SS; Lakin MM; Zippe CD
    Urology; 2005 Feb; 65(2):360-4. PubMed ID: 15708053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erectile dysfunction following nerve-sparing radical retropubic prostatectomy and its treatment with sildenafil.
    Shimizu T; Hisasue S; Sato Y; Kato R; Kobayashi K; Tsukamoto T
    Int J Urol; 2005 Jun; 12(6):552-7. PubMed ID: 15985077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
    Jaffe JS; Antell MR; Greenstein M; Ginsberg PC; Mydlo JH; Harkaway RC
    Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.